Company: MDCXW
Filing Date: 2025-03-28
Form Type: 253G2
Source: 0001062993-25-006502
Chunk: 154

Company: Medicus Pharma Ltd.
Filing Date: 2025-03-28
Form: 253G2
Chunk 154
---
 or relating to the Company may not be disclosed to others outside of the Company except as required in the performance of regular duties for the Company and in accordance with the Company's policies.

2.4This prohibition applies (but is not limited to) to any of the following persons or entities who are deemed to have a "special relationship" with the Company: (a) directors, officers and employees of the Company; (b) any person or company beneficially owning or controlling securities carrying more than 10% of the voting rights of the Company; (c) an associate of the Company as defined in the Securities Act (Ontario) or affiliate of the Company as defined in the Business Corporations Act (Ontario); (d) persons or corporations who learn of a material fact or material change concerning the Company from any person in a special relationship to the Company or ought reasonably to have known that the other person or company was in a special relationship with the Company; (e) any person or company that has engaged in, is engaging in or is proposing to engage in any business or professional activity with the Company, including any contractors and sub-contractors; or (f) any person who is associated with a person in a special relationship, including any family member, spouse or any other person living with such person, may also deemed to be a person in a special relationship with the Company, and therefore may be subject to the same legal obligations and duties.

<div align='center'>-3-</div>

2.5Unscheduled Blackout Periods:

(i)Additional blackout periods, due to material developments which may arise, as specified by the Chief Executive Officer or the Chief Financial Officer may be imposed from time to time. All directors, officers and employees of the Company with knowledge of such material developments will be covered by the blackout.

(ii)All directors, officers, consultants and employees of the Company, and its subsidiaries, and those persons deemed to have a "special relationship" with the Company or those associated with a person in a "special relationship" are subject to the following prohibitions relating to investments in the Company's securities:

(iii)If one has knowledge of a material fact or material change related to the affairs of the Company or any public issuer involved in a transaction with the Company which is not generally known, no purchase or sale of securities of the Company or such other public issuer may be made until the information has been generally disclosed to the public and the blackout periods set forth below have expired.

(iv)Knowledge of a material fact or